Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
2024

Exploring Olfactory Receptors as Drug Targets for Lung Diseases

publication 10 minutes Evidence: moderate

Author Information

Author(s): Awad Noha, Weidinger Daniel, Greune Lea, Kronsbein Juliane, Heinen Natalie, Westhoven Saskia, Pfaender Stephanie, Taube Christian, Reuter Sebastian, Peters Marcus, Hatt Hanns, Fender Anke, Knobloch Jürgen

Primary Institution: Bergmannsheil University Hospital, Ruhr-University Bochum

Hypothesis

Can olfactory receptors in lung epithelial cells serve as potential drug targets for non-type 2 lung diseases?

Conclusion

Olfactory receptors in the lung epithelium may play a role in airway sensitivity to odorants, suggesting their antagonism could be a promising treatment strategy for odorant-induced asthma with non-type 2 inflammation.

Supporting Evidence

  • Activation of OR51B5 and OR1G1 increased intracellular calcium levels in A549 cells.
  • Farnesol and Isononyl Alcohol reduced cell viability and induced IL-6 and IL-8 release.
  • Both receptors showed a preferential intracellular localization.
  • Stimulation of OR51B5 led to increased cAMP levels, suggesting a signaling pathway involved in cytokine release.

Takeaway

This study looks at how certain smell receptors in our lungs might help us understand and treat asthma caused by strong smells.

Methodology

The study used A549 cell lines and primary bronchial epithelial cells to investigate olfactory receptor expression and their effects on calcium signaling, cell viability, and cytokine release.

Limitations

The study primarily used in vitro models, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s10565-024-09935-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication